Negative symptoms of schizophrenia: a problem that will not go away
- PMID: 17201860
- DOI: 10.1111/j.1600-0447.2006.00947.x
Negative symptoms of schizophrenia: a problem that will not go away
Abstract
Objective: Negative symptoms of schizophrenia are a common, enduring, and debilitating component of the psychopathology of schizophrenia. Although efforts thus far to elucidate a distinct schizophrenia subtype based upon negative symptoms have yielded mixed results, there are nevertheless neurobiological correlates of the negative symptom typology.
Method: A review of nosology, typology, and assessment tools for determining core negative symptoms in schizophrenia.
Results: Negative symptoms can be difficult to evaluate objectively. Current rating scales 'capture' key domains of negative symptoms, in spite of considerable overlap between these domains. However, each objective assessment trades off methodological rigor and detail against brevity of assessment and ease of use.
Conclusion: The description of new methods for measuring these devastating symptoms, coupled with the ongoing development of novel antipsychotics and agents that augment antipsychotics have fuelled renewed interest in the evaluation of negative symptoms and optimism that better treatments for negative symptoms can be found.
Similar articles
-
Predictors of subjective and objective quality of life in outpatients with schizophrenia.Psychiatry Clin Neurosci. 2008 Aug;62(4):404-11. doi: 10.1111/j.1440-1819.2008.01818.x. Psychiatry Clin Neurosci. 2008. PMID: 18778437
-
[Primary and secondary negative symptoms: a useful differentiation? An empirical study].Nervenarzt. 1996 Jul;67(7):558-63. Nervenarzt. 1996. PMID: 8927194 German.
-
[Methodological constraints in evaluating anti-deficit effects].Encephale. 1996 Jun;22 Spec No 2:25-7. Encephale. 1996. PMID: 8767038 Review. French.
-
The impact of insight on functioning in patients with schizophrenia or schizoaffective disorder receiving risperidone long-acting injectable.J Nerv Ment Dis. 2007 Dec;195(12):976-82. doi: 10.1097/NMD.0b013e31815c1982. J Nerv Ment Dis. 2007. PMID: 18091190 Clinical Trial.
-
The treatment of negative symptoms: pharmacological and methodological issues.Br J Psychiatry Suppl. 1996 May;(29):17-22. Br J Psychiatry Suppl. 1996. PMID: 8733819 Review. No abstract available.
Cited by
-
The impact of motivation on cognitive performance in an animal model of the negative and cognitive symptoms of schizophrenia.Behav Neurosci. 2015 Jun;129(3):292-9. doi: 10.1037/bne0000051. Epub 2015 Apr 27. Behav Neurosci. 2015. PMID: 25914923 Free PMC article.
-
Differential Effect of Dopamine D4 Receptor Activation on Low-Frequency Oscillations in the Prefrontal Cortex and Hippocampus May Bias the Bidirectional Prefrontal-Hippocampal Coupling.Int J Mol Sci. 2022 Oct 3;23(19):11705. doi: 10.3390/ijms231911705. Int J Mol Sci. 2022. PMID: 36233007 Free PMC article.
-
Transcranial direct current stimulation in children and adolescents: a comprehensive review.J Neural Transm (Vienna). 2016 Oct;123(10):1219-34. doi: 10.1007/s00702-016-1572-z. Epub 2016 May 12. J Neural Transm (Vienna). 2016. PMID: 27173384 Review.
-
Interactive effects between hemizygous 15q13.3 microdeletion and peripubertal stress on adult behavioral functions.Neuropsychopharmacology. 2019 Mar;44(4):703-710. doi: 10.1038/s41386-018-0189-3. Epub 2018 Aug 27. Neuropsychopharmacology. 2019. PMID: 30188511 Free PMC article.
-
Impact of Negative Symptoms on Functioning and Quality of Life in First Psychotic Episodes of Schizophrenia.J Clin Med. 2022 Feb 14;11(4):983. doi: 10.3390/jcm11040983. J Clin Med. 2022. PMID: 35207256 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical